Jannick A N Dorresteijn Selected Research

Overweight

10/2019

Heterogeneity of Treatment Effects From an Intensive Lifestyle Weight Loss Intervention on Cardiovascular Events in Patients With Type 2 Diabetes: Data From the Look AHEAD Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jannick A N Dorresteijn Research Topics

Disease

13	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 01/2018
8	Diabetes Mellitus 04/2024 - 01/2011
7	Stroke (Strokes) 07/2023 - 01/2018
6	Myocardial Infarction 07/2023 - 01/2018
5	Vascular Diseases (Vascular Disease) 11/2023 - 01/2018
5	Hemorrhage 01/2023 - 01/2018
3	Albuminuria 03/2024 - 01/2019
3	Heart Failure 11/2023 - 01/2018
3	Ischemic Stroke 01/2022 - 01/2019
3	Hypertension (High Blood Pressure) 10/2018 - 01/2011
2	Thrombosis (Thrombus) 12/2023 - 01/2022
2	Coronary Artery Disease (Coronary Atherosclerosis) 07/2023 - 01/2017
2	Hypotension (Low Blood Pressure) 05/2023 - 01/2021
2	Neoplasms (Cancer) 01/2023 - 05/2022
2	Cognitive Dysfunction 01/2022 - 01/2022
2	Type 2 Diabetes Mellitus (MODY) 10/2019 - 01/2019
2	Atrial Fibrillation 01/2019 - 01/2018
2	Obesity 01/2017 - 01/2011
1	Unstable Angina 04/2024
1	Proteinuria 11/2023
1	Insulin Resistance 05/2023
1	Inflammation (Inflammations) 05/2023
1	Renal Insufficiency (Renal Failure) 12/2022
1	Acute Coronary Syndrome 01/2022
1	Heart Diseases (Heart Disease) 01/2022
1	Overweight 10/2019
1	Embolism (Embolus) 01/2019
1	Frailty 10/2018
1	Sudden Death 01/2018
1	Aneurysm (Aneurysms) 01/2018
1	Infarction (Infarctions) 01/2018
1	Rupture 01/2018
1	Coronary Disease (Coronary Heart Disease) 01/2018
1	Weight Loss (Weight Reduction) 01/2011

Drug/Important Bio-Agent (IBA)

5	CholesterolIBA 01/2023 - 01/2018
4	HDL CholesterolIBA 04/2024 - 01/2019
4	LipidsIBA 05/2023 - 01/2017
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 01/2017
3	omega-Chloroacetophenone (Mace)IBA 04/2024 - 10/2019
2	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 01/2019
2	C-Reactive ProteinIBA 11/2023 - 01/2023
2	CreatinineIBA 11/2023 - 01/2018
2	lipoprotein cholesterolIBA 05/2023 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2019 - 01/2019
2	Antihypertensive Agents (Antihypertensives)IBA 01/2018 - 01/2017
1	eicosapentaenoic acid ethyl esterIBA 04/2024
1	AlbuminsIBA 11/2023
1	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2023
1	CalciumIBA 10/2023
1	Colchicine FDA LinkGeneric 07/2023
1	AnticoagulantsIBA 01/2023
1	Dalteparin (Dalteparin Sodium)FDA Link 05/2022
1	edoxabanIBA 05/2022
1	Atorvastatin (Lipitor)FDA Link 01/2022
1	LDL CholesterolIBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	RivaroxabanIBA 12/2019
1	Insulin (Novolin)FDA Link 01/2019
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2019
1	Dabigatran FDA Link 01/2019
1	Retinaldehyde (Retinal)IBA 01/2018
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2018
1	Proprotein Convertase 9IBA 01/2018
1	DiureticsIBA 01/2011
1	SaltsIBA 01/2011

Therapy/Procedure

7	Therapeutics 11/2023 - 01/2017
1	Kidney Transplantation 12/2022
1	Secondary Prevention 01/2021
1	Drug Therapy (Chemotherapy) 01/2011